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KAJIAN FITOKIMIA DAN FARMAKOLOGI TERPILIH UNTUK 
EKSTRAK TERPIAWAI BUAH MORINDA CITRIFOLIA LINN. 
 
ABSTRAK 
 
Morinda citrifolia Linn. biasanya digunakan dalam kalangan orang tempatan 
Malaysia sebagai ubat tradisional untuk pelbagai jenis penyakit. Kini, terdapat 
sebelas jenis produk komersial buah Morinda citrifolia berdaftar di pasaran 
Malaysia. Dalam kajian ini, penyaringan fitokimia permulaan dan kajian fizikal-
kimia untuk serbuk buah diselidiki dan parameter kawalan mutu yang melibati 
profil kromatografi ekstrak dijalankan untuk pemiawaian tumbuhan.  
 
Kesan anti-angiogenik dari ekstrak buah telah dinilai dengan menggunakan kaedah 
membran korioalantoik embrio ayam (CAM). Ekstrak metanol dan fraksi 
kloroform memberikan kesan anti-angiogenik dengan nilai skor 0.94 dan 1.22 
masing-masing. Pengasingan bioaktiviti-bimbingan telah dilakukan dan scopoletin 
telah dikenalpastikan sebagai salah satu sebatian aktif dalam aktiviti anti-
angiogenik (nilai skor 1.39).  
 
Kesan sitotoksik ekstrak buah telah diperhati pada sel kanser payudara (MCF-7) 
dan sel leukemia manusia (HL-60) dengan menggunakan assai MTT. Ekstrak 
metanol telah merencat 37.6% sel MCF-7 dan 25.62% sel HL-60 pada kepekatan 
 xxiii 
30 ug/mL. Fraksi-fraksi yang lain dari buah talah menunjukkan aktiviti sitotoksik 
yang lebih lemah berbanding dengan ekstrak metanol.  
 
Adipogenesis disertai oleh pertumbuhan salur darah yang baru, dan dengan itu, 
penindasan angiogenesis akan menghalang adipogenesis dan obesiti. Kesan anti-
obesiti dan anti-hiperlipidemia telah diuji ke atas ekstrak metanol dan fraksi 
kloroform dengan menggunakan tikus hiperlipidemia induksi diet tinggi lemak. 
Hasilnya menunjukkan ekstrak buah mempengaruhi metabolisme trigliserida dan 
kolesterol pada tikus obesiti.  Ekstrak buah juga mengurangkan jumlah peningkatan 
berat badan tikus dengan ketara. 
 
Kajian antioksidan ekstrak buah telah dinilai dalam kajian ini. Fraksi etil asetat 
mengandungi kandungan fenolik (167.71 ± 5.30 ug/mL GAE) dan kandungan 
flavonoid (22.30 ± 1.22 ug/mL QE) yang tertinggi. Fraksi tersebut juga mempunyai 
aktiviti antioksidan yang tertinggi dalam penangkapan radikal DPPH dengan nilai 
EC50 164.09 ug/mL and mempunyai 83.46% aktiviti antioksidan dalam ujian β-
karoten-linoleat pada kepekatan 500 ug/mL. 
 
Kajian ini membekalkan maklumat kawalan mutu dan pemiawaian untuk ekstrak 
buah Morinda citrifolia. Kajian anti-angiogenik, sitotoksisiti, anti-obesiti, anti-
hiperlipidemia dan antioksidan membuktikan kegunaan tradisional buah ini untuk 
penyakit yang berkaitan.  
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PHYTOCHEMICAL AND SELECTED PHARMACOLOGICAL STUDIES 
OF STANDARDIZED FRUIT EXTRACTS OF MORINDA CITRIFOLIA 
LINN. 
 
ABSTRACT 
 
Morinda citrifolia is commonly used in Malaysia by locals as traditional medicine 
for various diseases. Currently there are eleven registered commercial products of 
Morinda citrifolia fruit available in Malaysia. In this study, preliminary 
phytochemical screening and physico-chemical studies of the fruit powder were 
attempted and quality parameter involving chromatographic profiling of the 
extracts were carried out for standardization.  
 
The fruit extracts were screened for anti-angiogenic effect using in vivo chick 
chorioallantoic membrane assay. Methanolic extract and chloroform fraction 
showed anti-angiogenic effect with the score value of 0.94 and 1.22, respectively. 
Bioactivity-guided isolation was performed and scopoletin was identified as one of 
the active constituents in anti-angiogenic activity (score value 1.39). 
  
Cytotoxic effects of the fruit extracts were observed on breast cancer cell lines 
(MCF 7) and human leukemia cell lines (HL-60) using MTT cell viability assay. 
The methanolic extract inhibited 37.6% of MCF 7 cells and 25.62% of HL-60 cells 
 xxv 
at concentration of 30 ug/mL. The other fractions of the fruit showed weaker 
cytotoxic activity than methanolic extract.  
 
Adipogenesis is concomitantly accompanied by new blood vessel growth, and thus 
suppression of angiogenesis would prevent adipogenesis and obesity. Methanolic 
extract and chloroform fraction were tested for their anti-obesity and anti-
hyperlipidemic effects using high fat diet induced hyperlipidemic rats. The finding 
showed the fruit extracts influenced triglyceride and cholesterol metabolism in 
obese rats.  The fruit extracts also significantly reduced the percentage of total body 
weight increased in the rats.  
 
Antioxidant activity of fruit extracts was evaluated in this study. Ethyl acetate 
fraction contains the highest phenolic content (167.71 ± 5.30 ug/mL GAE) and 
flavonoid content (22.30 ± 1.22 ug/mL QE). The fraction also possesses the highest 
antioxidant activity in DPPH scavenging with EC50 value 164.09 ug/mL and 
83.46% antioxidant activity in β-carotene-linoleate assay at the concentration of 
500 ug/mL. 
 
The present studies provided information on the quality and standardization of the 
fruit extracts. The anti-angiogenic, cytotoxicity, anti-obesity, anti-hyperlipidemic 
and antioxidant studies of the fruit provided evidence on the traditional use for 
related disease.  
 1 
CHAPTER 1 
INTRODUCTION 
1.1 General 
Herbal medicines are the therapeutic experiences of generations of practicing 
physicians of traditional medicine over hundreds of years and they are known to be 
oldest health care products that have been used by mankind all over the world to 
treat various types of ailments (Torey et al., 2010).  Recently, considerable 
attention has been paid to utilize eco-friendly and bio-friendly plant-based products 
for the prevention and cure of different human diseases.  It is documented that 80% 
of the world’s population has faith in traditional medicine, particularly plant drugs 
for their primary healthcare (Dubey et al., 2004). 
 
Modern technological medicine is nowadays much criticized for waiting for 
diseases to occur and then trying to cure it rather than seeking to prevent it from 
occurring in the first place (Laurence & Black, 1978).  Herbal products have played 
an important role today not only to heal the diseases but also to prevent the diseases 
from occurring.  The chemical constituents present in them are a part of the 
physiological functions of living flora and hence they are believed to have better 
compatibility with the human body and lesser side effects (Kamboj, 2000).  
 
There are estimated 350,000 flowering plant species identified so far, about 35,000 
species are used worldwide for medicinal purposes (Kong et al., 2003).  However, 
 2 
the number could be much higher as knowledge on the indigenous uses of plants 
was mostly passed on orally from one generation to another and has largely 
remained undocumented (Jantan, 2004).  Tropical rainforests cover about 12 % of 
the land area of the earth, Kong et al. (2003) reported that tropical rainforests are a 
vital source of medicines, there are not more than 1 % of the world's tropical forest 
plants have been tested for pharmaceutical properties, yet at least 25 % of all 
modern drugs originally came from rainforests.  
 
Morinda citrifolia is commonly used in Malaysia by local people as folk remedy to 
cure or to prevent diseases.  There are eleven registered commercial products of M. 
citrifolia fruit available in the market. In Malaysia, Morinda citrifolia L. 
(mengkudu besar) and Morinda elliptica Ridl. (mengkudu hutan) are the two 
common Morinda species.  Both of the species have their therapeutic effect. M. 
citrifolia is widely used to treat diabetes and M. elliptica is widely used to treat 
diarrhoea (Ong & Nordiana, 1999).  
 
1.2 Phytochemical and biological activities of genus Morinda 
The genus Morinda (Rubiaceae) is made up of around 80 species (Chan-Blanco et 
al., 2006).  In the Indo-Pacific region, species diversity is highest in Near Oceania 
with attenuation into Remote Oceania.  The genus Morinda includes trees, shrubs, 
and vines (McClatchey, 2003).  Morinda is a genus of the family Rubiaceae and 
has long been known to contain substantial amount of anthraquinones.  About 90% 
 3 
of these compounds occur as derivatives of 9,10-anthracenedione with several 
hydroxy and other functional groups, such as methyl, hydroxymethyl and carboxyl 
(Jasril et al., 2003).  Hydroxyanthraquinones are the active principles of many 
phyto-therapeutic drugs (Wolfle et al., 1990).  
 
1.2.1 Morinda elliptica 
Morinda elliptica Ridl. is a small plant known as “mengkudu kecil”.  It is a shrub 
or small tree, growing wild in newly developed arcas or in bushes. It is a native 
plant of Asia and Polynesia used in traditional folk medicine such as cholera, 
diarrhea, piles, headache and to increase appetite (Ismail et al., 1997; Ishak et al., 
2010). 
 
Ismail et al. (1997) reported a new anthraquinone and 10 known anthraquinones.  
The anthraquinone, 2-formyl-1-hydroxyanthraquinone and 10 known 
anthraquinones, 1-hydroxy-2-methylanthraquinone, nordamnacanthal, 
damnacanthal, lucidin-ω-methyl ether, rubiadin, soranjidiol, morindone, rubiadin-l-
methyl ether, alizarin-l-methyl ether and morindone-5-methyl ether were isolated 
from roots of M. elliptica.  The structures of the isolated compounds were shown in 
Figure 1.1. 
 
Jasril et al. (2003) tested the antitumor and antioxidant activities of six 
anthraquinones (nordamnacanthal, alizarin-1-methyl ether, rubiadin, soranjidiol, 
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lucidin-ω-methyl ether and morindone) of M. elliptica.  All compounds exhibited 
stronger antitumor activity than the reference compounds genistein and quercetin.  
In antioxidant assay using ferric thiocyanate (FTC) method, nordamnacanthal and 
morindone showed stronger antioxidant activity than α-tocopherol.  However when 
the compounds were assayed for scavenging activity of 1,1-diphenyl-2-
picrylhydrazyl (DPPH) free radicals, only morindone was considered to be active 
as free radical scavenger.  This observation suggested that radical scavenging is 
less prominent in nordamnacanthal as compared to morindone.  The differences 
between the two compounds are that the formyl at C-2 and hydroxyl at C-3 in 
nordamnacanthal are replaced by a methyl and proton groups, respectively in 
morindone. 
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1. 2-formyl-1-hydroxyanthraquinone           2. nordamnacanthal 
 
                                   
                 3. alizarin-1-methyl ether               4. rubiadin 
 
                      
                  5. soranjidiol             6. lucidin-ω-methyl ether  
Figure 1.1 Isolated compounds from the roots of Morinda elliptica 
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                       7. morindone   8. 1-hydroxy-2-methylanthraquinone 
 
                                           
                                               9. damnacanthal  
                                                                                                                                                    
                                                                                                               
                    10. morindone-5-methyl ether            11. rubiadin-l-methyl ether 
Figure 1.1 (continued) Isolated compounds from the roots of Morinda elliptica 
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1.2.2 Morinda morindoides 
Morinda morindoides Milne-Redh, is one of the most popular medicinal plants 
currently used in villages and towns in Democratic Republic of Congo in 
traditional medicine.  An aqueous decoction of fresh leaves, which is the typical 
traditional remedy used for the treatment of various illnesses among which are 
diarrhoea and constipation associated with intestinal worms (Cimanga et al., 2010).
  
Marie-Genevieve et al. (2010) reported that the in vitro effect of the toluene, 
methyl tert-butyl ether (MtBE), ethyl acetate (EtOAc), n-butanol (n-BuOH) and 
water extracts from M. morindoides leaves on their cytotoxicity effect against 
leukemic cell lines.  They found that both toluene and MtBE extracts exhibited a 
significant cytotoxic effect on the cell lines.  The highest cytotoxicity was obtained 
with toluene extract.  By contrast, EtOAc, n-BuOH and water extracts did not 
affect cell viability of the three cell lines tested.  
 
Cimanga and co-workers reported M. morindoides leaf extracts have been shown to 
possess antiprotozoal activity particularly against Entamoeba histolytica (Cimanga 
et al., 2006).  Extracts, fractions and some isolated compounds from M. 
morindoides leaves were tested for their potential in vitro antiamoebic activity.  
Results indicated that the aqueous decoction (dried extract) and 80% methanolic 
extract displayed an appreciable antiamoebic activity.  The CHCl3, EtOAc and n-
BuOH soluble fractions from the partition of 80% methanolic extract exhibited an 
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average antiamoebic activity.  The residual water-soluble fraction showed a weak 
effect against Entamoeba histolytica. 
 
A number of isolated compounds from the leaf of M. morindoides were reported 
(Cimanga et al., 2006).  The structures of the compounds are shown in Figure 1.2. 
 
              
           12. quercetin                                      13. quercetin-7,4 prim-dimethylether 
 
                       
14. quercetin-3-O-rutinoside 
Figure 1.2 Isolated compounds from the leaf of Morinda morindoides 
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15. kaempferol-3-O-rhamnoside           16. kaempferol 
 
                             
                               17. kaempferol-3-O-rutinoside 
Figure 1.2 (continued) Isolated compounds from the leaf of Morinda 
morindoides 
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                         18. luteolin                       19. gaertneroside 
 
                       
      20. gaertneric acid                        21. epoxygaertneroside 
Figure 1.2 (continued) Isolated compounds from the leaf of Morinda morindoides 
 
 
 
 
 
 11 
1.2.3 Morinda officinalis  
Morinda officinalis How, is one of the traditional Chinese plants grows in humid 
areas of southeast China.  It has been reported to possess the ability to reinforce 
kidney function, strengthen the tendons and bones and relieve rheumatic condition.  
This plant is also claimed for its anti-diabetic effects and may have an 
antidepressant-like action (Soon & Tan, 2002; Zhang et al., 2002). 
 
Zhang and co-workers (2009) reported the polysaccharides from the roots of M. 
officinalis were found to have significant anti-fatigue activity by using mice 
weight-loaded swimming model.  The activity may be related to the anti-stress and 
enhancing immunity effects of M. officinalis.  The anti-fatigue activity of the 
polysaccharides may partially explained the tonic property in traditional medicine, 
which provided scientific evidence for traditional medicine and further 
development of medicinal products for prevention and treatment of diseases related 
to chronic fatigue syndromes. 
 
Five anthraquinones including alizarin-1-methylether, 1,2-dimethoxy-3 
hydroxyanthraquinone, 1-hydroxy-3-hydroxymethylanthraquinone, rubiadin-1-
methylether and anthragallol-2-methylether were isolated from the dried roots of M. 
officinalis How (Zhu et al., 2009).  The structures of the isolated compounds are 
shown in Figure 1.3. 
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      22. alizarin-1-methylether  23. 1,2-dimethoxy-3 hydroxyanthraquinone 
 
                                    
24. 1- hydroxy-3-hydroxymethylanthraquinone            25. rubiadin-1-methylether 
 
                                               
             26. anthragallol-2-methylether 
Figure 1.3 Compounds isolated from the dried roots of M. officinalis How 
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1.2.4 Morinda lucida  
Morinda lucida Benth, is a tropical West Africa rainforest tree also called 
Brimstone tree.  Different parts of the plant are attributed with diverse therapeutic 
benefits.  For example, in Southern Cameroon, cold decoction of the plant leaves is 
used for the treatment of fever.  However, in most parts of West Africa, the bitter 
water decoction of the plant bark, root and leaf are used as bitter tonic and as 
astringent for dysentery, abdominal colic and intestinal worm infestation (Adeneye 
& Agbaje, 2008).  
 
Raji et al. (2005) investigated the effect of M. lucida on the reproductive activity of 
male albino rats.  M. lucida leaf extract did not cause any changes in body and 
somatic organ weights, but significantly increased the testis weight (P < 0.05).  The 
sperm motility and viability, and the epididymal sperm counts of rats treated for 13 
weeks were significantly reduced (P < 0.05).  Sperm morphological abnormalities 
and serum testosterone levels were significantly increased (P < 0.05).  There were 
various degrees of damage to the seminiferous tubules.  The extract reduced the 
fertility of the treated rats by reducing the litter size. 
 
The antibacterial activity of M. lucida was investigated against Staphylococcus 
aureus, Bacillus subtilis, Pseudomonas aeruginosa, Escherichia coli and 
Salmonella typhi using the Kirby–Bauer agar diffusion method. The bark 
methanolic extract of M. lucida inhibited the growth of the above mentioned 
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bacteria with the MIC values below 20 mg/mL.  Phytochemical screening was 
performed on the plant extract and the tests suggested the presence of saponins, 
flavonoids, alkaloids, terpenoids, tannins and anthraquinones in the plant 
(Gbedema et al., 2010). 
 
The chemical constituents isolated from M. lucida were reported by Adesogan 
(1973).  The structures of these chemical constituents are shown in Figure 1.4. 
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                           27. oruwal                        28. oruwalol 
 
                                   
                        29. damnacanthal           30. nordamnacanthal 
 
                                          
              31. alizarin-1-methyl ether             32. rubiadin 
Figure 1.4 Compounds isolated from Morinda lucida Benth. 
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         33. rubiadin-1-methylether   34. 2-methyl-anthraquinone 
 
                                               
                                35. 1-methoxy-2-methyl-anthraquinone 
 
 
                                                   36. hexacosanoic acid 
Figure 1.4 (continued) Compounds isolated from Morinda lucida Benth. 
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1.2.5 Morinda angustifolia 
Morinda angustifolia Roxb, is a resourceful perennial undershrub, and widely 
distributed in the southwestern mountainous areas of China, and nearby countries, 
such as Burma, Laos, Thailand and India.  The major usage of the plant is to make 
yellow fabric dye stuff (Xiang et al., 2008).  
 
Bhuyan and Saikia (2005) reported that the isolated morindone from the root 
benzene extract of M. angustifolia was the colour component responsible for 
dyeing.  Dyes derived from natural sources have emerged as important alternatives 
to synthetic dyes, which have been reported to have carcinogenic effects.  Recently 
with the worldwide concern over the use of eco-friendly and biodegradable 
materials, the use of natural dyes has once again gained interest.  
 
Xiang and co-workers (2008) studied the antimicrobial activity of M. angustifolia.  
Six isolated compounds (1,8-dihydroxy-2-methyl-3,7- dimethoxyanthraquinone, 
lucidin 3-O-β-primeveroside, 1,3-dihydroxy-2-methylanthraquinone, lucidin- ω -
ethyl ether, lucidin-ω-butyl ether and damnacanthol) were tested for their 
antimicrobial potential against Bacillus subtilis, Escherichia coli, Micrococcus 
luteus, Sarcina lutea, Staphylococcus aureus, Aspergillus niger, Candida albicans 
and Saccharomyces sake.  Among the compounds, 1,8-dihydroxy-2-methyl-3,7- 
dimethoxy anthraquinone demonstrated the most significant antimicrobial activity 
against Bacillus subtilis, Escherichia coli, Micrococcus luteus, Sarcina lutea, 
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Candida albicans and Saccharomyces sake. The structures of the isolated 
compounds are shown in Figure 1.5. 
 
                         
         37. 1,8-dihydroxy-2-methyl-3,7-                     38.damnacanthol 
              dimethoxyanthraquinone 
 
                                                                                         
            39. lucidin-ω-butyl ether               40. 1,3-dihydroxy-2-methylanthraquinone   
 
                       
         41. lucidin 3-O-β-primeveroside                          42. lucidin- ω -ethyl ether 
Figure 1.5 Structures of the isolated compounds from the roots of M. angustifolia 
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1.3 Plant Morinda citrifolia Linn.            
1.3.1 Plant taxonomy 
Kingdom: Plantae 
Sub kingdom: Tracheobionta 
Super division: Spermatophyta 
Division: Magnoliopsida 
Class: Magnoliopsidae 
Subclass: Asteridae 
Order: Rubiales 
Family: Rubiaceace 
Genus: Morinda 
Species: Morinda citrifolia  
Common name: Noni (Hawaii or island of Polinesia) or mengkudu (Malaysia) 
 
Retrieved from: http://ethnoakmal.blogspot.com/2009/02/mengkudu-noni-morinda-
citrifolialinn.html (September, 2011) 
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Figure 1.6 The fruit of Morinda citrifolia (with flowers) 
 
 
Figure 1.7 Young fruit of Morinfa citrifolia 
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1.3.2 Plant morphology 
Morinda citrifolia is a bush or small tree, 3–10 m tall, with abundant wide elliptical 
leaves (5–17 cm length, 10–40 cm width).  The small tubular white flowers are 
grouped together and inserted on the peduncle.  The petioles leave ring-like marks 
on the stalks and the corolla is greenish white (Chan-Blanco et al., 2006).  
 
M. citrifolia fruit (Figure 1.6 and Figure 1.7) is oval in shape and will turn from a 
greenish to a yellowish-white color when it ripens.  It has a bitter taste and exhales 
a strong butyric acid-like pungent smell.  The seeds have a distinct air chamber, 
and can retain viability even after floating in water for months (Nelson, 2003).  The 
roots and inner bark may have little coloration or may range from bright yellow to 
red. 
 
1.3.3 Plant habitat and distribution 
The plant habitat ranges from tropical rainforest to dry lowland plains, from the 
coast to elevated inland sites.  It can tolerate exposed sites as well as the relatively 
thin and infertile soils.  The plant is present worldwide predominantly in tropical 
countries.  M. citrifolia occurs in Africa, Australia, Barbados, Cambodia, 
Caribbean, Cayman Islands, Cuba, Dominican Republic, El Salvador, Fiji, Florida, 
French West Indies, Guadeloupe, Guam, Haiti, Hawaii, India, Jamaica, Java, Laos, 
Malaysia, Marquesas Islands, Philippines, Polynesia, Puerto Rico, Raratonga, 
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Samoa, Seychelles, Solomon Islands, Southeast Asia, St. Croix, Surinam, Tahiti, 
Thailand, Tonga, Trinida and Tobago and Vietnam (Mathivanan et al., 2005). 
 
1.3.4 Uses in traditional medicine 
M. citrifolia has been used in folk remedies by Polynesians for over 2000 years, 
and is reported to have a broad range of therapeutic effects, including antibacterial, 
antiviral, antifungal, antitumor, analgesic, hypotensive, anti-inflammatory, 
antidiabetic and immune enhancing effects (Wang et al., 2002).  
 
Dixon et al. (1999) and Morton (1992) reported the fruit of M. citrifolia was 
traditionally used to treat gum disorder, tuberculosis, anthelmintic and as purgative.  
The fruit pulp can be used as an insecticidal shampoo.  The flower was applied to 
treat sore eye.  The leaves of the plant was used to treat wounds, ulcers, ringworm, 
rheumatic pain, inflammation, liver diseases, internal bleeding, abdominal swollen, 
fever, headache, cough and cold.  The bark was used to treat malaria and finally the 
root was consumed to cure hypertension.  
 
Nelson (2003) reported the teas from the leaves were used as treatment for malaria 
and analgesic in Africa.  All parts of the plants are useful laxative.  Decoctions of 
the stem bark are consumed to treat jaundice and the extract of the leaves is for 
hypertension.  Other usages such as to treat sprains, deep bruising, toothaches, 
fractures, diabetes, loss of appetite, urinary tract ailments, abdominal swelling, 
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hernias, stings from stonefish and human vitamin A deficiency were also reported 
by the author. 
 
1.3.5 Literature survey  
Yong et al. (2006) studied the free-radical-scavenging activity of M. citrifolia juice 
and powder in processing and storage.  The authors proposed the fresh juice M. 
citrifolia possessed free-radical-scavenging activity (RSA), 1,1-diphenyl-2-
picrylhydrazyl (DPPH), at 140 mg equivalent ascorbic acid/100 mL and total 
phenols at 210 mg gallic acid/100 mL.  Fermentation of the fruit for 3 months 
resulted in a loss of more than 90% of RSA.  Dehydration at 50 
o
C produced a loss 
of 20% of RSA.  Storage of fresh fruit juice at 24
o
C for 3 months reduced RSA 
more than 90%.  Storage of fruit juice or powder at -18
o
C and 4
o
C for 3 months 
decreased RSA by 10–55%.  For maintenance of the substantial antioxidant 
properties of M. citrifolia fruit products, processing of fruit powder or fresh frozen 
fruit juice rather than fermented fruit juice is recommended. 
 
Pawlus et al. (2005) isolated a new anthraquinone, 2-methoxy-1,3,6-
trihydroxyanthraquinone from the fruit of M. citrifolia.  The compound was 
reported to have potent quinone reductase (QR) induction activity, which is 40 
times more potent than a positive control, L-sulforaphane.  Furthermore, this 
compound demonstrated no discernible cytotoxicity at the highest dose tested.  QR 
is a phase II metabolizing enzyme.  The induction of phase II enzymes is 
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considered cancer chemopreventive in that potential oxidative and electrophilic 
molecules can be more readily metabolized and excreted before they can interact 
with cellular macromolecules such as DNA.  QR is also responsible for maintaining 
the reduced states of antioxidants such as R-tocopherol and coenzyme Q10.  Hence, 
QR inducers are sometimes referred to as “indirect antioxidants”, and this activity 
is considered protective at the initiation stage of carcinogenesis.  The chemical 
structures of 2-methoxy-1,3,6-trihydroxyanthraquinone together with a few known 
isolated compounds were shown in Figure 1.8. 
 
Taskin et al. (2009) investigated the apoptosis-inducing effects of M. citrifolia and 
doxorubicin on the Ehrlich ascites tumor in Balb-c mice and also combined it with 
a potent anti-cancer agent, doxorubicin.  The first group of animal received M. 
citrifolia fruit only, the second group of animal received doxorubicin, and the third 
group of animal received both M. citrifolia fruit and doxorubicin for 14 days after 
the inoculation of cells.  The control group received 0.9% NaCl only.  The result 
found that short and long diameters of the tumor tissues were about 40–50% 
smaller and the proliferation was decreased, compared to those in control group.  
This anti-growth effect resulted from the induction of apoptosis.  The authors 
concluded M. citrifolia fruit may be useful in the treatment of breast cancer either 
on its own or in combination with doxorubicin. 
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    43. 2-methoxy-1,3,6-trihydroxy-                             44. 1,3-dihydroxy-2-methoxy- 
          anthraquinone                                                              anthraquinone 
 
 
 
                              
45. 1,6-dihydroxy-5-methoxy-2-                      46. 1,8-dihydroxy-2- hydroxymethyl-   
       methylanthraquinone                                        5-methoxyanthraquinone                                                                                                                                       
 
 
                                                                      
 
 
                                       
                                  47. 2-hydroxy-1-methoxyanthraquinone 
Figure 1.8 Isolated compounds by Pawlus et al. (2005) 
